Linda Given Welch, CNM, MS | |
3633 W Lake Ave Ste 204, Glenview, IL 60026-5802 | |
(847) 729-2108 | |
Not Available |
Full Name | Linda Given Welch |
---|---|
Gender | Female |
Speciality | Advanced Practice Midwife |
Location | 3633 W Lake Ave Ste 204, Glenview, Illinois |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043330749 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163W00000X | Registered Nurse | (Illinois) | Primary |
367A00000X | Advanced Practice Midwife | (Illinois) | Primary |
Mailing Address | Practice Location Address |
---|---|
Linda Given Welch, CNM, MS 3633 W Lake Ave Ste 204, Glenview, IL 60026-5802 Ph: (847) 729-2108 | Linda Given Welch, CNM, MS 3633 W Lake Ave Ste 204, Glenview, IL 60026-5802 Ph: (847) 729-2108 |
News Archive
The New York Times on Wednesday published an editorial and column that addressed a provision included in a Medicare bill (HR 6331) passed by the House that would delay for 18 months a competitive bidding program for durable medical equipment.
Misunderstandings about proper use of antibiotics have the potential to spread widely through social networks such as Twitter, according to a report in the April issue of AJIC: American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology, Inc. (APIC).
Exelixis, Inc. announced today that cabozantinib will be the subject of nine separate data presentations at the upcoming 2013 Annual Meeting of the American Society of Clinical Oncology.
New IMBRUVICA (ibrutinib) Phase II data announced here today by Pharmacyclics, Inc) during the 56th American Society of Hematology Annual Meeting suggests that IMBRUVICA demonstrates anti-tumor activity both as a single-agent and as combination therapy in heavily pre-treated patients with relapsed or relapsed/refractory multiple myeloma (MM).
› Verified 3 days ago